Life insurance after percutaneous revascularization in a patient with severe left ventricular dysfunction and left bundle branch block: benefit of revascularization in the post-REVIVED-BCIS2 era

The recent results of the REVIVED-BCIS2 randomized clinical trial added further controversy on the utility of myocardial revascularization in patients with chronic coronary syndrome with reduced ejection fraction. However, coronary artery disease still represents the leading cause of heart failure w...

Full description

Saved in:
Bibliographic Details
Published in:Giornale italiano di cardiologia (2006) Vol. 25; no. 8; p. 609
Main Authors: Piedimonte, Giulio, Rolfo, Cristina, Tomassini, Francesco, Galluzzo, Alessandro, Cerrato, Enrico, Pavani, Marco, Franzè, Alfonso, Varbella, Ferdinando
Format: Journal Article
Language:Italian
Published: Italy 01-08-2024
Subjects:
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The recent results of the REVIVED-BCIS2 randomized clinical trial added further controversy on the utility of myocardial revascularization in patients with chronic coronary syndrome with reduced ejection fraction. However, coronary artery disease still represents the leading cause of heart failure with reduced ejection fraction, with the potential for functional recovery following complete revascularization due to the restoration of the so-called hibernating myocardium. We report an emblematic case of a patient with recovery of contractile function and normalization of the left bundle branch block after percutaneous coronary intervention of the right coronary artery chronic total occlusion.
ISSN:1972-6481
DOI:10.1714/4309.42931